Hepatic Uptake of Technetium-99m-MDP on Bone Scintigraphy Associated with Intravenous Iron Therapy

病患為60歲男性，最近兩週出現黃膽及臉色蒼白的症狀，以貧血及疑似胃癌的診斷住院，在接受靜脈注射鐵劑ATOFEN之後作骨骼掃描，骨骼掃描出現異常的肝臟攝取；ATOFEN是一種治療貧血的用藥，在靜脈注射之後，此種鐵膠質會快速的進入肝臟的網狀內皮系統，被吞食的鐵膠質會和鎝－99m-MDP作用造成骨骼掃描上的肝臟顯影。

關鍵字

鐵劑；鎝－99m-MDP ；肝臟顯影

並列摘要

A 60-year-old male complained of progressing pale and jaundice in recent 2 weeks. Under the impression of anemia and suspicious gastric cancer, he received intravenous iron therapy with iron chondrointin-sulfate colloid (ATOFEN) and underwent a whole body bone scan afterwards. Diffuse hepatic uptake of (superscript 99m)Tc-MDP was demonstrated on bone scintigraphy. ATOFEN is a potent anti-anemic agent with a favorable pharmacokinetic profile. After intra-venous injection, most of the injected iron colloid immediately distributes to hepatic reticuloendothelial cells. Phagocytized iron colloid contributes to hepatic uptake of (superscript 99m)Tc-MDP in our patient who underwent ATOFEN therapy.

並列關鍵字

iron therapy ； (superscript 99m)Tc-MDP ； liver uptake

國際替代計量

Hepatic Uptake of Technetium-99m-MDP on Bone Scintigraphy Associated with Intravenous Iron Therapy

全文下載

主題瀏覽